Marshall Wace’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-158,411
| Closed | -$2.36M | – | 2477 |
|
|
2023
Q3 | $2.36M | Sell |
158,411
-623,324
| -80% | -$9.29M | ﹤0.01% | 1004 |
|
|
2023
Q2 | $8.56M | Buy |
781,735
+538,554
| +221% | +$5.9M | 0.02% | 696 |
|
|
2023
Q1 | $2.12M | Buy |
243,181
+161,401
| +197% | +$1.41M | ﹤0.01% | 1143 |
|
|
2022
Q4 | $513K | Buy |
+81,780
| New | +$513K | ﹤0.01% | 1807 |
|
|
2022
Q3 | – | Sell |
-11,000
| Closed | -$33K | – | 3340 |
|
|
2022
Q2 | $33K | Buy |
+11,000
| New | +$33K | ﹤0.01% | 2609 |
|
|
2019
Q2 | – | Sell |
-63,589
| Closed | -$844K | – | 1914 |
|
|
2019
Q1 | $844K | Buy |
63,589
+9,231
| +17% | +$123K | 0.01% | 981 |
|
|
2018
Q4 | $428K | Buy |
+54,358
| New | +$428K | ﹤0.01% | 1153 |
|